Previous Page  12 / 16 Next Page
Information
Show Menu
Previous Page 12 / 16 Next Page
Page Background

Page 42

allied

academies

Biol Med Case Rep 2017 | Volume 1 Issue 2

November 06-07, 2017 | New Orleans, USA

Nanomedicine & Healthcare

Global Meet on

N

ano-encapsulation of drugs involves formation of drug

loaded particles with diameters ranging from 1 to 1000

nm. Nanospheres have a matrix type structure with drugs

being absorbed either at the sphere surface or encapsulated

within the particle. Nano-capsules are vesicular systems

in which the drug is confined to a cavity consisting of an

inner liquid core surrounded by a polymeric membrane. In

this case, the active substances are usually dissolved in the

inner core, but may also be adsorbed to the capsule surface.

Nano-encapsulation of drugs increases their efficacy,

specificity and targeting ability and protect their payload

from premature degradation in the biological environment,

enhance bioavailability, and prolong presence in blood

and cellular uptake. Peptide drugs are attracting increasing

interest now-days with better understanding of their role in

physiopathology, as well as progress in biotechnology and

biochemical synthesis. However, the use of peptides and

proteins in medicine has been limited by low bioavailability,

which results from their poor stability to proteolytic and

hydrolytic degradation, low permeability across barriers,

and short biologic half-life in the circulatory system. Most

therapeutic peptides are still, being administered by the

parenteral route because of insufficient absorption from

the gastrointestinal tract (GIT). Bioavailability of drug is

defined as a measurement of the extent of a therapeutically

active component that reaches the systemic circulation

and is available at the site of action. It is one of the

key pharmacokinetic properties of a phytochemical or

drug. Phytochemicals with health benefits, such as plant

polyphenols (that is, curcumin, resveratrol, epigallocatechin

gallate, and so on) and carotenoids (that is, lycopene,

β-carotene, lutein, zeaxanthin, and so on), have received

much attention from the scientific community, consumers,

and food manufacturers because they can be used to

lower blood pressure, reduce cancer risk factors, regulate

digestive tract system, strengthen immune systems, regulate

growth, sugar concentration in blood, lower cholesterol

levels, and serve as antioxidant agents. Although, the use

of polyphenols in capsules and tablets is abundant, their

biological effects are frequently diminished or even lost due

to incomplete absorption and first-pass metabolism. Overall,

the therapeutic use of drug molecule is limited due to poor

solubility, poor permeability, instability and extensive first

past metabolism before reaching the systemic circulation.

Many researchers have attempted to improve its solubility

by adding non-polar solvents (DMSO), synthesis of water

soluble derivative and complexation with cyclodextrin and

liposomes. However, the encapsulation of drug molecule

on suitable nano-carriers is one of the promising ways to

circumvent these problems. Hence, the present work focuses

on various nano-encapsulation strategies for successful

targeted drug delivery.

e:

kgnathan27@rediffmail.com

Nanoencapsulation of bioactive metabolites of local medicinal plants for effective drug delivery and its

efficacy test using laboratory animal models

K Gurunathan

and

N Suganthy

Alagappa University, India